Targeting tetraspanins in cancer. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Expert Opinion on Therapeutic Targets Year : 2012

Targeting tetraspanins in cancer.


Introduction: Tetraspanins are a family of small proteins that cross the membrane four times and form complexes by interacting between themselves and with a variety of transmembrane and cytosolic proteins, building a network of interactions referred to as tetraspanin web or tetraspanin enriched microdomains (TEMs). These domains provide a signaling platform involved in many important cellular functions and malignant processes. Areas covered: The authors describe the methods and the rationale for targeting tetraspanins in the therapy of cancer in this review. Expert opinion: Targeting tetraspanins in cancer may be a promising therapy due to the importance of tetraspanins in several steps of tumor formation, communication with the environment, dissemination, and metastasis.
Embargoed file
Embargoed file
Ne sera jamais visible

Dates and versions

inserm-00724944 , version 1 (23-08-2012)



Monica Sala-Valdes, Naouel Ailane, Céline Greco, Eric Rubinstein, Claude Boucheix. Targeting tetraspanins in cancer.. Expert Opinion on Therapeutic Targets, 2012, 32 (1), epub ahead of print. ⟨10.1517/14728222.2012.712688⟩. ⟨inserm-00724944⟩


154 View
0 Download



Gmail Facebook Twitter LinkedIn More